Much has been said and written on the topic of the recent report from the U.S. Department of Labor regarding the supposed inadequacy of the workers' compensation system. Critics rightly point out that the report appears to reduce its own credibility by failing to exhibit a sufficient understa...Read More
State: NA | Segment: Top | 515 | 0 | Popular with Legal
Ohio has proposed something novel: Let's not pay for expensive naloxone prescriptions and instead invest resources in ensuring the delivery of appropriate medical care and provide help for those struggling with dependence and addiction.
State: NA | Segment: Top | 872 | 0 | Popular with Legal
We all know that lobbyists exist. We all know the role they play in American politics, however frustrating that fact might be to us. We all know that pharmaceutical companies have plenty of them, and they appear to be pretty good at their jobs.
The Food and Drug Administration has scheduled hearings for November (and a public comment period that will extend to January) regarding the agency's current approach to the marketing of off-label uses of FDA-...Read More
Whether or not opioid pain medication might actually worsen pain is a legitimate clinical discussion and an important claims management topic. While the phenomenon is researched and written about in medical journals, talked about at various conferences and acknowledged among physicians, I ha...Read More
Amidst all the talk of seven-day initial opioid script limits in New York, Massachusetts and New Hampshire (with New Jersey, Connecticut and others likely not far behind), we appear to have missed a piece of legislation that, in my view, represents the single most stringent legal construct f...Read More
Hardly a day, a conference, a meeting or a case goes by without a serious discussion about the need for a "biopsychosocial" approach to injury resolution. In fact, I've recently heard griping in some circles that the discussion has run its course. "We get it ... can w...Read More